sarcoma Flashcards

1
Q

synovial sarcoma systemic regimens

A

Adriamycin, ifosfamide, mesna (AIM)
High dose ifosfamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SOC for osteogenic osteosarcoma

A

Neoadjuvant cisplatin, doxorubicin, and high dose methotrexate (MAP)
Surgery
Additional adjuvant MAP chemotherapy (systemic disease that requires intense systemic chemotherapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

First line chemotherapy for osteogenic osteosarcoma

A

Neoadjuvant cisplatin, doxorubicin, and high dose methotrexate (MAP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of low-grade localized chondrosarcoma

A

Upfront surgical resection
Given low grade, observation with serial imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Giant cell tumor management

A

Upfront surgery
*no role for radiation or chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Angiosarcoma of the breast management

A

mastectomy alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Preferred second line for GIST

A

Repritinib (INVICTUS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Second line for dedifferentiated liposarcoma

A

Eribulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

management of recurrent desmoid tumor

A

sorafenib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management of recurrent giant cell tumor

A

Denosumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Firstline for GIST harboring PDGFRA exon 18 mutation

A

avapritinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Trabectedin SE to know

A

Rhabdomyolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

First line for metastatic osteosarcoma

A

IF >40, cisplatin/doxorubicin without high dose methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of desmoid fibromatosis in pregnant patient

A

Monitor (DF that develops within 6 months of pregnancy may regress without intervention, so watchful waiting appropriate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GIST management with c-kit exon 9 mutation

A

higher starting dose of imatinib (400 mg BID) (higher mitotic rate and increased recurrence risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Preferred second line for GIST

A

ripretinib

17
Q

first line for epithelial sarcoma

A

Tazemotostat

18
Q

Management of retroperitoneal leiomyosarcoma

A

surgery alone

19
Q

Preferred second line for KS

A

Taxol

20
Q

First line systemic therapy for metastatic soft tissue sarcoma

A

Doxorubicin